# NEULANDLAB share price, delivery % and history — Neuland Laboratories Limited

> Delivery percentage for Neuland Laboratories Limited (NEULANDLAB) against its own history, with 4,404 sessions of split-adjusted NSE data from 2008 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/NEULANDLAB

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 21,350 INR (-0.12% on the day), 2026-09-30
- Delivery: 55.19% of volume taken to demat (20-day average 48.99%)
- Volume: 51.3K shares, turnover ₹109.5Cr
- Relative volume: 1.09× of its own 20-day average

## Technicals

- RSI(14): 36.99
- ATR(14): 701.32
- SMA 50: 22,006.48, SMA 200: 16,931.96
- 52-week range: 11,500 – 24,225 (-11.87% from the high)

## Performance

- 1 week -5.07%, 1 month -7.21%, 3 months 12.44%
- 6 months 76.93%, 1 year 42.48%

## Delivery percentage

- Latest: 55.19% (2026-09-30)
- 20-day average: 48.99%
- 1-year average: 37.4%
- Percentile against its own history: 67th
- Range: 6.2% – 100% across 1,728 sessions with a reading

Over the last 20 sessions NEULANDLAB settled 49.0% of its traded quantity, which is above average for an NSE equity. Its one-year average is 37.4%, so recent sessions are running 11.6 points higher than usual. The latest session ranks higher than 67% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 27,391.8 crore
- P/E (TTM): 55.03 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 387.98 INR, split-adjusted to match the price series
- Revenue growth: 119.15% YoY, -17.35% QoQ
- Profit growth: 962.4% YoY, -30.56% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 20.44% | 21.7% |
| 3y | 21.18% | 32.2% |
| 4y | 25% | 66.32% |
| 5y | 20.53% | 46.33% |
| 6y | 20.18% | 63.91% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 310.8 | 265.8 | 49.4 | 32.8 | 25.6 | 10.57% |
| 2024-12-31 | 398 | 330 | 127.8 | 101.6 | 79.18 | 25.52% |
| 2025-03-31 | 328.4 | 296.5 | 39.3 | 27.8 | 21.67 | 8.47% |
| 2025-06-30 | 292.8 | 283 | 17.6 | 13.9 | 10.83 | 4.75% |
| 2025-09-30 | 514.3 | 386.6 | 129.4 | 96.9 | 75.49 | 18.83% |
| 2025-12-31 | 439.7 | 393.3 | 54.5 | 40.6 | 31.62 | 9.23% |
| 2026-03-31 | 776.3 | 501.2 | 287.5 | 212.7 | 165.76 | 27.4% |
| 2026-06-30 | 641.6 | 452.2 | 197.8 | 147.7 | 115.1 | 23.02% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 32.62%
- Public: 67.38%
- FII: 21.08%, DII: 16.51%
- Promoter shares pledged: 2.29%

## Recent filings

- 2026-08-05: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_182772_05082026180411_iXBRL_WEB.html
- 2026-07-24: dividend
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1696377_20072026085555_WEB.xml
- 2026-05-12: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_157059_12052026205010_iXBRL_WEB.html
- 2026-04-11: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1649252_11042026113922_WEB.xml
- 2026-02-09: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_141245_09022026165412_iXBRL_WEB.html
- 2026-01-07: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1596083_07012026035607_WEB.xml
- 2025-11-07: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_125133_07112025172637_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 114 events are indexed for this instrument.

## About the instrument

- Listed: 2008-10-13 — latest session 2026-09-30 (4,404 sessions)
- ISIN: INE794A01010
- Series: EQ
- Liquidity rank: #283 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/NEULANDLAB.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.